Stock UniverseDerived research view · source repositories remain read-only

Aardvark Therapeutics, Inc. (AARD)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
29.41
Global Rank
2115
Market Cap
271.95M
Latest Close
3.68
RS Composite
-55.63% · G#3308

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-37.52%
3M
-37.09%
6M
-69.15%
1Y
-68.55%
3Y
-74.28%
5Y
-74.28%
10Y
-74.28%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 130.60K · 30-day average: 164.38K · Max drawdown over stored range: -79.84%

Research Snapshot

Relative Strength vs SPX

RS Composite-55.63%
20D RS-34.92%
60D RS-38.20%
120D RS-83.42%
Global RS Rank3308 · 1.40% percentile
Watch+Speculative RS Rank2054 · 2.05% percentile
Group ScopeWatch+Speculative
Primary RS Rank442 · 3.49% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank332 / 701
Primary Percentile52.78
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for AARD.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2022FY 2023FY 2024FY 2025
Revenue
Revenue Growth (YoY)
Gross Profit
Operating Income-10.363-7.415-22.785
Free Cash Flow-10.543-5.824-18.196-54.267
Free Cash Flow Per Share-2.709-1.47-4.553-2.7652501504996834
EPS (Diluted) GAAP-3.485426-1.819768-5.151667
EPS Growth
EPS Non-GAAP
Gross Margin
Operating Margin
Profit Margin
Free Cash Flow Margin
Shares Outstanding (Diluted)3.89163.96093.996419.6246
Shares Change (YoY)5700%1.781%0.895%391.061%

SEC Quarterly Fundamentals

No processed quarterly rows for AARD.